Iwaki FY25 sales rise 2.7% on strong chemical demand
Iwaki (TSE:6237) reported a 2.7% increase in net sales for the fiscal year ended March 31, 2025, reaching JPY45.763 billion, up from JPY44.539 billion the previous year. The company cited strong performance in the chemicals category and improvements in water treatment, particularly in Japan and the United States, as key drivers. Operating profit rose 7.0% to JPY5.845 billion. Net income per share saw a slight decrease to JPY202.15. The company forecasts FY26 sales of JPY48.439 billion and is raising its dividend payout ratio to 35% or more. Iwaki anticipates continued growth in water treatment and medical equipment, and a recovery in the semiconductor market.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Iwaki publishes news
Free account required • Unsubscribe anytime